Aurista Pharma Private Limited, a active private limited company, was established on 11 June 2021 in Roorkee, Uttarakhand, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24239UR2021PTC012510. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
Its leadership includes Manju Rani (Director), Umesh Chandra Sharma (Director), Rahul Kumar (Director). Past directors included Umesh Chandra Sharma, Rahul Kumar, Deepak Kumar Kaushal. It holds ₹3.50 M open charges and ₹1.00 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Mrs Soniya W/O Parmod Kumar Near Evredy Store Gorshi Kunj Paniyala, Roorkee, Uttarakhand, 247667.
U24239UR2021PTC012510
012510
11 June 2021
₹1.50 M
₹1.50 M
Roc Uttarakhand
Unlisted
Active
Explore comprehensive insights into Aurista Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manju Rani | Director | 11 Jun 2021 | Current |
| Umesh Chandra Sharma | Director | 10 Oct 2022 | Current |
| Rahul Kumar | Director | 10 Oct 2022 | Current |
| Deepak Kumar Kaushal | Director | 10 Oct 2022 | Current |
| Pramod Kumar | Director | 11 Jun 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aurista Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 463.36% increase. The company also saw a substantial improvement in profitability, with a 104530.19% increase in profit. The company's net worth Soared by an impressive increase of 14.74%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Aurista Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹3,500,000.00
₹1,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jul 2025 | Others | ₹3.50 M | Open |
| 21 Mar 2023 | Others | ₹1.00 M | Satisfied |
Explore comprehensive loan charge details -
Aurista Pharma has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aurista Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurista Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Aurista Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity A charge registered on 21 Mar 2023 via Charge ID 100715019 with Others was fully satisfied on 11 Jul 2025. was completed.
A charge with Others amounted to Rs. 3.50 M with Charge ID 101138725 was registered on 08 Jul 2025. was recorded as a recent event.
Aurista Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand. was recorded as a recent event.
A charge with Others amounted to Rs. 1.00 M with Charge ID 100715019 was registered on 21 Mar 2023. was recorded as a recent event.
The activity Umesh Chandra Sharma was appointed as a Director was appointed as a Director on 10 Oct 2022 & has been associated with this company since 3 years 2 months . was completed.
The CIN of Aurista Pharma Private Limited is U24239UR2021PTC012510.
Aurista Pharma Private Limited is headquartered at Mrs Soniya W/O Parmod Kumar Near Evredy Store Gorshi Kunj Paniyala, Roorkee, Uttarakhand, 247667.
Aurista Pharma Private Limited was incorporated on 11 June 2021.
The current directors of Aurista Pharma Private Limited are
The primary industry of Aurista Pharma Private Limited is Trade.
Aurista Pharma Private Limited is unlisted.
The authorized capital of Aurista Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX